AMN vs GILD · rev $2.98B vs P/E 18, rev $29.44B
AMN Healthcare Services Inc (AMN) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AMN currently screens at market cap $1.23B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AMN and GILD stock pages for the full models.
Not investment advice.